How one patient survived COVID-19

How one patient survived COVID-19
View As Webpage

Fortinet leaders delve into healthcare cybersecurity strategies >>
 
HIMSS
 
 

Monday, June 29, 2020

 
 
Brainlab and Level Ex logos

Medical video game maker Level Ex acquired by surgical technology firm Brainlab

By Dave Muoio

Level Ex, a Chicago startup that makes medical-training video games for doctors, has been acquired by Berlin-based medical-technology company Brainlab, the companies announced today.

The companies did not disclose the terms of their deal, although Level Ex CEO Sam Glassenberg told MobiHealthNews that his company would continue to operate under the new ownership as an independent entity.

"We're a bunch of game developers that have been parachuted into the healthcare industry, and we're constantly seeing technology that is, like, two decades behind what we're doing in the entertainment industry," he said. "Brainlab is the exception. If you go to their offices and see their tech, it's incredibly forward looking. And not just from the standpoint of amazing 3D graphics and rendering technology, but the integration of all the tools into a seamless digital experience in the operating room."

Level Ex offers a handful of mobile video games that challenge physicians with hypothetical cases or procedures within different medical specialties, such as interventional cardiology. These scenarios are designed to refresh players' knowledge or help familiarize them with the use of a new medical device, and in some cases can provide continuing medical education (CME) credits upon completion. Level Ex funds the development of these games through deals with pharmas and device manufacturers, in which the customers' specific devices and treatments are featured within the game.

Brainlab is a roughly 1,400-person company that focuses on a range of hardware and software technologies for cranial, spinal, trauma, orthopedic, otorhinolaryngology and craniomaxillofacial surgeries. Glassenberg said that Level Ex has had a relationship with the company for years, thanks to a project involving the game-maker's graphics-rendering technology, and he is most excited by Neurolab's work on emerging new software technologies.

"You know how neurosurgery and brain surgery have the reputation of sort of being the most cutting edge in medicine? It's Brainlab. It's unbelievable," he said. "They are on the absolute cutting edge of digital transformation in medicine – completely digital ORs, trajectory planning, where you can overlay 3D volumetric MRI data, and ultrasound data, and everything. These are the first guys to jump on augmented reality for use in the operating room."

WHAT'S THE IMPACT

First and foremost, Glassenberg described the acquisition as a chance for his startup to scale its business. The German company gives Level Ex an opportunity to pursue international clients, and to establish immediate business relationships with Brainlab's existing medical device, pharmaceutical and life sciences partners.

"Right now we're already working with six out of the top 10 pharmaceutical companies, and a number of the top 10 medical device companies ... to help disseminate best practices and accelerate the adoption of their products," he said. "Being part of Brainlab only helps accelerate that, and accelerate our growth."

At the same time, Glassenberg said that his team's game design expertise will also have a role to play in the advancement of Brainlab's various digital products.

"They have a digital OR where different medical devices can integrate so they can be tracked. So inside the operating room you get to see where the device is inside the patient by looking at the imagery. For us, we can use our video game technology and video game design to not only help doctors train on those devices and understand how to use them, but develop their skills on a virtual patient."

THE LARGER TREND

The news comes just a few weeks after another medical game-maker, digital-therapeutics company Akili Interactive, received its long-awaited De Novo clearance for EndeavorRx. And while Level Ex's video games have fairly unique goals – physician education versus treatment of pediatric ADHD symptoms – Glassenberg said that both the clearance and his company's acquisition signal an increasing recognition of video games' role within the industry.

"This really demonstrates that gaming in healthcare is no longer theoretical," he said. "We have real solutions here that are going to have long-standing impacts on the healthcare ecosystem."

Prior to these developments Level Ex released free additions to two of its respiratory-focused games, which were designed to help providers prepare for challenging COVID-19 patient scenarios. Glassenberg said they have so far received "incredibly inspiring" feedback from physician players.

The company also has an ongoing project with the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine that's focused on building virtual simulations of how routine medical procedures can be upended during low-gravity.

Kopa App and Web screen shot

Happify Health releases new chronic condition management platform, Kopa for Psoriasis >>

By Mallory Hackett

Happify Health, known for its digital mental health programs, today released a platform targeted towards people with chronic conditions, called Kopa.

The first component of this new platform is Kopa for Psoriasis, a product created to provide resources and community for those living with the condition.

The company chose to first focus on psoriasis because of the comorbidities often associated with it, such as stress, depression, anxiety, self-consciousness and impaired social functioning.

WHAT’S THE IMPACT?

Psoriasis is a global problem, with at least 100 million individuals affected worldwide, according to the World Health Organization.

Because psoriasis is such a complex condition, WHO also says that simply prescribing medications is “insufficient to control the disease and a holistic, whole-person approach to care is needed.”

Kopa for Psoriasis offers three main components on the platform, which can be accessed on the mobile app or web page.

The first is a community feed where people can connect to share advice, give support and discuss personal experiences related to the condition.

The second aspect of the app connects patients with medical professionals so they can receive treatment recommendations and up-to-date information about psoriasis.

Finally, the app curates educational resources that can help people manage their flare-ups and offer assistance around how psoriasis affects work, relationships, and guidance to improve sleep, diet, exercise and mental health.

Kopa for Psoriasis plans to add new features for the community in the coming months.

THE LARGER TREND

The company is best known for its digital mental health programs that are intended to be affordable and accessible for employers to roll out for their workers.

In another move made last week, Happify Health unveiled a partnership with the American Heart Association for a digital mental health program for people with high blood pressure and high cholesterol.

Also in the chronic-care digital-management sphere is Lark, which released an AI-powered prevention tool earlier this year.

ON THE RECORD

“With the launch of Kopa, we’re reimagining how healthcare is delivered to people with chronic conditions,” Tomer Ben-Kiki, cofounder and CEO of Happify Health, said in a statement. “Our goal is to provide easily accessible tools, personalized content, community support and access to medical experts to help people live happier, more fulfilling lives.”

 

ADVERTISEMENT

Keeping the focus on patients. AWS is how. >>

TELEHEALTH

After initial spike, telehealth visits are on the decline, report finds

Data from 50,000 healthcare providers suggests that ambulatory practice visits have not rebounded to pre-pandemic levels.

 

DIGITAL THERAPEUTICS

Masimo announces device designed to reduce opioid withdrawal symptoms

The device applies electrical impulses to the cranial nerves around the ear, which can reduce neuron activity and opioid withdrawal symptoms.

 

FUNDING & IPOS

Health insurtech company Oscar scores $225M in new funding

Alphabet, General Catalyst, Kholsa Ventures, Lakestar, Thrive Capital and Baillie Gifford participated in this round.

 

POPULATION HEALTH

New Irish contact tracing app ‘less invasive than Alexa’

A new monitoring system funded under the European Open Science Cloud initiative will allow users with symptoms of coronavirus to participate in national track-and-trace while maintaining privacy.

 

DIGITAL THERAPEUTICS

SidekickHealth secures multimillion-dollar deal with Pfizer

The firms are collaborating to launch a digital medication management and lifestyle platform across Europe.

 

HIMSS TV

How one patient survived COVID-19

Health IT professional Frank Cutitta, now 100 days in care, gives a firsthand look at what healthcare gets right, and wrong.

 

HIMSS INSIGHTS

COVID-19 and Beyond

The latest issue in the HIMSS Insights series focuses on the implications of the coronavirus crisis for healthcare and healthcare digitization. Several months into the crisis at the time of publication, we try to identify major trends coming out of COVID-19 and unmet digital needs that are being unmasked. The second area of focus is digital health technology assessment which is arising in several healthcare systems and remains highly relevant during the pandemic and beyond.

 

ADVERTISEMENT

RPA: Transformation Through Automation >>
 

Focusing on privacy and security in the coronavirus new normal >>

ADAPTING TO THE "NEW NORMAL"

This month we look at how the COVID-19 pandemic is fundamentally changing healthcare organizations' approaches to security, now and in the future.

Facebook Twitter LinkedIn

MobiHealthNews & HIMSS Media.
Editorial Inquiries | Advertising | Privacy Policy | Unsubscribe

33 West Monroe Street, Suite 1700, Chicago, IL 60603-5616